Founder: Curzio Rüegg
Xemperia has developed a blood test for breast cancer screening and early detection of relapse. This test is based on the analysis of multiple specific biomarkers derived from blood leukocytes. It can be integrated into current diagnostic procedures and will help doctors make decisions for personalized treatments.
Home